Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamsung El.gdr Regulatory News (SMSN)

Share Price Information for Samsung El.gdr (SMSN)

Share Price is delayed by 15 minutes
Get Live Data
5,600.00    180.00 (3.32%)
Bid:
5,590.00
Ask:
5,610.00
Spread: 20.00 (0.358%)
Market Cap: $1.47t
SMSN Live PriceLast checked at - London Stock Exchange

Intraday Samsung El.gdr Share Chart

  • This share is an international stock.

Decision on Share Repurchase

18 Mar 2026 08:28

RNS Number : 1318X
Samsung Electronics Co. Ld
18 March 2026
 

Decision on Share Repurchase

1. Number of shares to be repurchased

Common

37,000,000

Other

-

2. Value of shares to be repurchased (Korean won)

Common

7,174,300,000,000

Other

-

3. Expected repurchase period

Start date

March 19, 2026

End date

June 18, 2026

4. Expected holding period

Start date

-

End date

-

5. Purpose of repurchase

To facilitate employee stock-based compensation

6. Method of repurchase

Open market

7. Consignment investment brokers

Samsung Securities Co., Ltd.

Shinhan Securities Co., Ltd.

KB Securities Co., Ltd.

8. Holding status of treasury shares before repurchase

Repurchase within the allowable distribution profit (shares)

Common

120,813,769

Ratio (%)

2.0

Other

13,603,461

Ratio (%)

1.7

Other repurchase (shares)

Common

-

Ratio (%)

-

Other

-

Ratio (%)

-

9. Date of board resolution (confirmation date)

March 18, 2026

- Attendance of Independent Directors at the Board of Directors meeting

Present

5

Absent

-

- Attendance of auditors who are not

 Independent Directors

-

10. Daily order quantity limit

Common

8,656,922

Other

-

 

11. Other information to consider:

- Shares denoted as "other" are preferred shares.

- In Item 1 above, number of shares to be purchased was calculated based on the closing price on the day prior to the Board's resolution (March 17, 2026).

(KRW 193,900 per common share)

- The Company plans to acquire treasury shares based on the value of shares to be repurchased in Item 2 above. The actual amount may change depending on future stock price movements.

- With respect to Items 4 and Items 5 above, the Company is repurchasing shares that will be held in treasury for use in stock-based compensation programs, including Performance Stock Units (PSUs; introduced in October 2025) as well as in other programs to incentivize employee performance (e.g., OPI, LTI).

- In Item 9 above, all Audit Committee members are Independent Directors.

- The calculation method for Item 10 above is the smaller of: [] and [the larger of and ].

  10% of the number of shares to be repurchased: 3,700,000 common

  25% of average daily transaction volume over the one month period preceding the date of the board resolution: 8,656,922 common

  1% of total number of issued shares: 59,196,379 common

 

- Limit on the amount of repurchased shares (Korean won)

1. Limits to Dividend eligible profit under Commercial Act as of end-2025

243,066,826,669,885

2. Amount of repurchased shares since end-2025

6,073,607,225,640

3. Amount of dividends on profits and reserves for related profits decided at a general meeting of shareholders since end-2025

3,753,484,329,311

4. The interim dividend amount and related profit reserves decided by the board of directors since end-2025

-

5. Acquisition cost of the shares in disposing of treasury shares since end-2025

826,550,373,780

Limit on the amount of repurchased shares

(1-2-3-4+5)

234,066,285,488,714

- In Item 1 above, 'Limits to Dividend eligible profit under Commercial Act as of end-2025' is based on the 2025 financial statements approved at the general meeting of shareholders as of the report submission date (March 18, 2026)

-In Item 2 above, 'Amount of repurchased shares since end-2025' represents the book value, including related fees and expenses

 

- Holding status of treasury shares before purchase (number of shares)

* on-market direct purchase

Stock type

Initial quantity

Changes

End quantity

Purchase

Disposal

Cancellation

Common

91,828,987

36,793,671

7,808,889

-

120,813,769

Other

13,603,461

-

-

-

13,603,461

 

* The 'Initial quantity' represents the number of shares held on as of January 1, 2026, the first day of the fiscal year in which the disclosure document was prepared; and the 'End quantity' refers to the number of shares held on March 18, 2026, the day the disclosure document was prepared.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCZZGMFRRDGVZG
Date   Source Headline
26th Apr 20189:40 amRNSTransaction with Affiliate Company
26th Apr 20189:27 amRNSPurchase of Assets
26th Apr 20189:22 amRNSTransaction with Affiliate Company
26th Apr 20187:00 amRNSQuarterly Dividend for First Quarter 2018
26th Apr 20187:00 amRNS2018 1Q Earnings Release
20th Apr 20187:39 amRNSUpdate on Stock Split
6th Apr 20187:00 amRNS1Q 2018 Pre-Earnings Guidance
6th Apr 20187:00 amRNSTransaction with Affiliate Company
6th Apr 20187:00 amRNSNotice of 1Q 2018 Earnings Release Schedule
23rd Mar 20187:32 amRNSCharitable Contribution
23rd Mar 20187:25 amRNSTransaction with Affiliate Company
23rd Mar 20187:23 amRNSResults of the 49th Annual General Meeting
23rd Mar 20187:13 amRNSAppointment of New Representative Directors
16th Mar 20187:10 amRNSDecision on Stock Split(Update)
14th Mar 20187:00 amRNSRecord Date for Proposed Dividends
28th Feb 20187:44 amRNS2017 Consolidated Financial Statements
23rd Feb 20189:03 amRNSCharitable Contribution
23rd Feb 20189:02 amRNSReference Material for 2018 AGM
6th Feb 20189:50 amRNSTrial Court Judgment relating to Embezzlement
31st Jan 20187:54 amRNSDecision on Stock Split
31st Jan 20187:43 amRNSCharitable Contribution
31st Jan 20187:25 amRNSTransaction with Affiliate Company
31st Jan 20187:00 amRNSYear-End Cash Dividend for FY2017
31st Jan 20187:00 amRNS2017 4Q Earnings Release
30th Jan 20188:32 amRNSResults of Share Repurchase Program
29th Jan 20188:46 amRNSTrial Court Judgment relating to Embezzlement
9th Jan 20187:51 amRNSNotice of 4Q 2017 Earnings Release Schedule
9th Jan 20187:00 amRNS4Q 2017 Pre-Earnings Guidance
29th Dec 20177:00 amRNSCorporate Governance Report 2017
15th Dec 20177:02 amRNSAnnouncement of Record Date for AGM
29th Nov 20177:22 amRNS2017 3Q Interim Report
24th Nov 20177:10 amRNSTransaction with Affiliate Company
24th Nov 20177:06 amRNSCharitable Contribution
2nd Nov 20177:00 amRNSSale of Business Operations (Update)
31st Oct 20177:00 amRNSAnnouncement of CAPEX Plan for FY 2017
31st Oct 20177:00 amRNSApproval of Share Repurchase and Cancellation Plan
31st Oct 20177:00 amRNSShareholder Return Program for FY2018-2020
31st Oct 20177:00 amRNSQuarterly Dividend for Third Quarter 2017
31st Oct 20177:00 amRNS2017 3Q Earnings Release
13th Oct 20178:06 amRNSNotice of 2017 Q3 Earnings Release Schedule
13th Oct 20177:00 amRNS2017 3Q Pre-Earnings Guidance
22nd Sep 20178:09 amRNSNotice of 2017 Q3 Pre-Earnings Guidance Schedule
12th Sep 20178:16 amRNSRecord Date for Proposed Dividends
29th Aug 20178:48 amRNS2017 Half Year Report
29th Aug 20177:00 amRNSTransaction with SCS
29th Aug 20177:00 amRNSTrial Court Judgment relating to Embezzlement
27th Jul 20178:28 amRNSResponse to disclosure inquiry regarding news
27th Jul 20178:17 amRNSRenewal of Property and Casualty Insurance
27th Jul 20177:56 amRNSApproval of Share Repurchase and Cancellation Plan
27th Jul 20177:51 amRNSQuarterly Dividend for Second Quarter 2017

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.